Eucalyptus-M (Tablets, Pastilles) Instructions for Use

ATC Code

R07AX (Other drugs for the treatment of respiratory diseases)

Active Substances

Eucalyptus oil (BP British Pharmacopoeia)

Levomenthol (Rec.INN WHO registered)

Clinical-Pharmacological Group

A drug with antimicrobial and anti-inflammatory action for topical use in ENT practice

Pharmacotherapeutic Group

Antiseptic of plant origin

Pharmacological Action

It exerts a local anti-inflammatory and antiseptic action.

Indications

Use for symptomatic relief of inflammatory conditions affecting the upper respiratory tract and oropharyngeal mucosa.

• Pharyngitis;
• Laryngitis;
• Tracheitis.

ICD codes

Dosage Regimen

Adhere strictly to the recommended dosage and method of administration for the specific pharmaceutical form.

For tablets, dissolve completely in the mouth without chewing. For adults, administer 1 tablet 3-4 times daily. For children from 8 years old, administer 1-2 tablets per day.

For pastilles, apply topically 1 to 4 times per day, with frequency determined by age. Do not exceed a treatment duration of 5 days.

Adverse Reactions

Monitor for signs of hypersensitivity and gastrointestinal discomfort during therapy.

Possible adverse effects include allergic reactions and, rarely, dyspeptic symptoms.

Discontinue use immediately and consult a physician if any unlisted side effects occur.

Contraindications

Do not administer under any circumstances to patients with specific conditions or sensitivities.

• Confirmed hypersensitivity to eucalyptus oil, levomenthol, or any excipient.
• Patients under 8 years of age due to lack of safety data and risk of adverse effects.
• Hereditary fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase deficiency.

Use in Pregnancy and Lactation

Use of the drug during pregnancy and breastfeeding is not recommended due to the lack of safety data for use in this category of patients.

Pediatric Use

Use of the drug is contraindicated in children under 8 years of age.

Special Precautions

If symptoms of the disease persist or the condition worsens during the use of the drug for 5 days, the patient should inform the attending physician.

Effect on the ability to drive vehicles and mechanisms

The use of the drug does not affect the ability to perform potentially hazardous activities requiring increased concentration and speed of psychomotor reactions (driving vehicles, working with moving mechanisms).

Overdose

No specific antidote exists; management is supportive and directed at symptom relief.

No cases of overdose have been reported. In the event of suspected excessive ingestion, provide symptomatic and supportive care. Monitor for gastrointestinal distress or neurological symptoms.

Drug Interactions

Exercise caution with concomitant use of antidiabetic agents and herbal preparations.

Eucalyptus may potentiate the effect of antidiabetic drugs, leading to hypoglycemia. Monitor blood glucose levels closely.

Avoid concurrent use with herbs containing pyrrolizidine alkaloids due to increased risk of hepatotoxicity.

Storage Conditions

The drug should be stored out of the reach of children at a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life – 3 years. Do not use after the expiration date.

Dispensing Status

The drug is available without a prescription.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.